Reset
Showing 11 of 71 academic articles

Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis

Antonio Cervadoro, Roberto Palomba, Giuseppe Vergaro, Giuseppe Vergaro et al. • Frontiers in Bioengineering and Biotechnology (2018)

Atherosclerosis (AS) is a disorder of large and medium-sized arteries; it consists in the formation of lipid-rich plaques in the intima and inner media, whose pathophysiology is mostly driven by inflammation. Currently available interventio...

DOAJ Open Access (DOAJ) DOI: 10.3389/fbioe.2018.00177

Externally triggered drug delivery systems

Huiyang Hu, Prabhakar Busa, Yue Zhao, Chao Zhao • Smart Materials in Medicine (2024)

Externally triggered drug delivery systems empower patients or healthcare providers to utilize external stimuli to initiate drug release from implanted systems. This approach holds significant potential for clinical disease management, offe...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.smaim.2024.08.004

Impact of Nanotechnology on Drug Delivery

Omid Cameron Farokhzad, Róbert Langer • ACS Nano (2009)

Nanotechnology is the engineering and manufacturing of materials at the atomic and molecular scale. In its strictest definition from the National Nanotechnology Initiative, nanotechnology refers to structures roughly in the 1-100 nm size re...

OPENALEX DOI: https://doi.org/10.1021/nn900002m

Encyclopedia of nanotechnology

Bharat Bhushan • Choice Reviews Online (2013)

The Encyclopedia of Nanotechnology provides a comprehensive and multi-disciplinary reference to the many fields relevant to the general field of nanotechnology. It aims to be a comprehensive and genuinely international reference work and wi...

OPENALEX DOI: https://doi.org/10.5860/choice.50-3014

Nanotechnology and medicine

Dwaine F. Emerich, Christopher G. Thanos • Expert Opinion on Biological Therapy (2003)

Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medi...

OPENALEX DOI: https://doi.org/10.1517/14712598.3.4.655

Nanomedicine for Glioblastoma: Cutting-Edge Advances and Persistent Challenges

Ladi Alik Kumar, K Sunand, Jitendra Debata, Gopal Krishna Padhy et al. • Journal of Bio-X Research (2025)

Cancer is a disorder characterized by the abnormal growth of cells that increases uncontrollably over an extended period of time. Treating cancerous brain tumors remains among the most challenging tasks for researchers, as brain tumors are ...

DOAJ Open Access (DOAJ) DOI: 10.34133/jbioxresearch.0065

Computer vision and machine‐learning techniques for quantification and predictive modeling of intracellular anticancer drug delivery by nanocarriers

Sanjay Goswami, Kshama D. Dhobale, Ravindra D. Wavhale, Barnali Goswami et al. • Applied AI Letters (2022)

Abstract The field of cancer nanomedicine has made significant progress, but its clinical translation is impeded by many challenges, such as the difficulty in analyzing intracellular anticancer drug release by the nanocarriers due to the la...

DOAJ Open Access (DOAJ) DOI: 10.1002/ail2.50

PharmaNet Deep: Real-Time Pharmaceutical Defect Detection Using Defect-Guided Feature Fusion and Uncertainty-Driven Inspection

Ajantha Vijayakumar, Joseph Abraham Sundar Koilraj, Muthaiah Rajappa • International Journal of Computational Intelligence Systems (2025)

Abstract Oral dosage forms are the most widely employed method of drug delivery in therapeutic treatments. However, the presence of visual defects in blister packages can adversely affect the drug's bioavailability and therapeutic efficacy,...

DOAJ Open Access (DOAJ) DOI: 10.1007/s44196-025-00986-2

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies

Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine (2026)

Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12967-026-07966-w

Artificial intelligence in nanomedicine

Dean Ho, Peter Wang, Theodore Wonpeum Kee • Nanoscale Horizons (2018)

The field of nanomedicine has made substantial strides in the areas of therapeutic and diagnostic development. For example, nanoparticle-modified drug compounds and imaging agents have resulted in markedly enhanced treatment outcomes and co...

OPENALEX DOI: https://doi.org/10.1039/c8nh00233a